Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
5.81
+0.18 (3.20%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Lexeo Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 430 | 725 | 218 | 358 | - | - | |
| Market Cap Growth | 554.87% | 233.00% | -39.13% | - | - | - | |
| Enterprise Value | 257 | 610 | 71 | 523 | - | - | |
| Last Close Price | 5.81 | 9.93 | 6.58 | 13.42 | - | - | |
| PB Ratio | 1.72 | 2.94 | 1.86 | 3.15 | - | - | |
| P/TBV Ratio | 1.75 | 2.94 | 1.86 | 3.15 | - | - | |
| Debt / Equity Ratio | 0.03 | 0.03 | 0.09 | 0.10 | 0.19 | - | |
| Net Debt / Equity Ratio | -0.70 | -0.70 | -0.95 | -0.97 | -0.89 | -1.05 | |
| Net Debt / EBITDA Ratio | 1.60 | 1.60 | 1.06 | 1.62 | 1.06 | 2.68 | |
| Net Debt / FCF Ratio | 1.76 | 1.76 | 1.37 | 1.84 | 1.16 | 3.06 | |
| Asset Turnover | - | - | - | - | 0.01 | 0.02 | |
| Quick Ratio | 10.81 | 10.81 | 5.32 | 7.05 | 5.39 | 18.24 | |
| Current Ratio | 11.21 | 11.21 | 5.52 | 7.21 | 5.58 | 18.35 | |
| Return on Equity (ROE) | -55.00% | -55.00% | -85.37% | -71.54% | -58.84% | -65.27% | |
| Return on Assets (ROA) | -32.86% | -32.86% | -46.11% | -36.15% | -32.33% | -38.07% | |
| Return on Capital Employed (ROCE) | -43.40% | -43.40% | -85.20% | -55.90% | -73.10% | -39.10% | |
| Earnings Yield | -23.22% | -13.79% | -45.18% | -18.57% | - | - | |
| FCF Yield | -22.99% | -13.65% | -37.51% | -16.67% | - | - | |
| Buyback Yield / Dilution | -68.76% | -68.76% | -493.67% | -228.42% | -5.00% | -7.72% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.